Free Trial

Rafferty Asset Management LLC Has $860,000 Holdings in Walgreens Boots Alliance, Inc. $WBA

Walgreens Boots Alliance logo with Retail/Wholesale background

Key Points

  • Rafferty Asset Management LLC has decreased its holdings in Walgreens Boots Alliance by 26.3%, selling 27,464 shares and bringing its total to 77,005 shares valued at approximately $860,000.
  • Several large investors, including Charles Schwab Investment Management and Northern Trust Corp, have recently increased their stakes in Walgreens Boots Alliance, indicating shifting investor interest in the company.
  • For the latest quarter, Walgreens Boots Alliance reported earnings of $0.38 per share, surpassing analysts’ expectations and achieving 7.2% revenue growth year-over-year.
  • Interested in Walgreens Boots Alliance? Here are five stocks we like better.

Rafferty Asset Management LLC cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 26.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 77,005 shares of the pharmacy operator's stock after selling 27,464 shares during the period. Rafferty Asset Management LLC's holdings in Walgreens Boots Alliance were worth $860,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of WBA. Colonial Trust Co SC raised its stake in shares of Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,297 shares during the last quarter. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth approximately $27,000. Curat Global LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth approximately $27,000. Federated Hermes Inc. raised its stake in shares of Walgreens Boots Alliance by 135.8% during the first quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock worth $35,000 after buying an additional 1,815 shares during the last quarter. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth approximately $43,000. 58.59% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They set a "hold" rating for the company. Finally, UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat, Walgreens Boots Alliance has a consensus rating of "Reduce" and a consensus price target of $10.15.

View Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA remained flat at $11.98 during trading hours on Friday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $13.25. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. The stock has a market cap of $10.37 billion, a PE ratio of -1.64, a P/E/G ratio of 1.42 and a beta of 0.80. The stock has a fifty day moving average of $11.75 and a 200-day moving average of $11.32.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The firm had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. During the same quarter in the prior year, the firm earned $0.63 earnings per share. The business's quarterly revenue was up 7.2% on a year-over-year basis. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Should You Invest $1,000 in Walgreens Boots Alliance Right Now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.